Valeant Pharma eyes NC office

Raleigh, North Carolina's News & Observer reports that California-based Valeant Pharmaceuticals is in discussions for an office building in Durham. The developer already has 25 employees in the Research Triangle Park area, but that number could grow significantly if the company plans to boost its presence there. Article

Suggested Articles

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.

The appointments are part of Verona’s efforts to prepare for phase 3 development of ensifentrine in chronic obstructive pulmonary disease.

Syntimmune has had a roller-coaster few years, losing CEOs, gaining new ones and then being snapped up by Alexion in 2018 for up to $1.2 billion.